Letrozole in Postmenopausal Women at Increased Risk for Breast Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study to see what happens to breast density in healthy postmenopausal
women after treatment with letrozole in one year, compared with treatment with placebo for
one year. Other goals of the study include determining if there is a connection between
estrogen level and breast density for women in the study and collecting information about the
quality of life of those taking part in the study.
Phase:
Phase 2
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Beth Israel Deaconess Medical Center Brigham and Women's Hospital Massachusetts General Hospital